11:11 AM EDT, 07/29/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week trending modestly lower late Monday morning, declining 0.30% to 1,419.50 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by electronics company Philips (PHG) and biopharmaceutical company Genfit ( GNFT ) , which climbed 13% and 5.7%, respectively. They were followed by furniture manufacturer Natuzzi (NTZ) and medical device maker EDAP TMS ( EDAP ) , which increased 2.7% and 2.4%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and semiconductor company Sequans Communications ( SQNS ) , which fell 6.9% and 4.5%, respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and brewing company Anheuser-Busch InBev ( BUD ) , which dropped 4.3% and 3.1%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and TC Biopharm ( TCBP ) , which rose 5.7% and 4.8% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and pharmaceutical company AstraZeneca ( AZN ) , which were up 1.4% each.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Bicycle Therapeutics ( BCYC ) , which lost 3.6% each. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and biotech firm Autolus Therapeutics ( AUTL ) , which were down 2.3% each.